Literature DB >> 16041536

Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India.

A H Heald1, S G Anderson, A Vyas, K Siddals, J Patel, A P Yates, D Bhatnagar, D Prabhakaran, E Hughes, A Rudenski, P Durrington, J M Gibson, J K Cruickshank.   

Abstract

AIMS/HYPOTHESES: We previously reported independent links between the IGF system and the development of impaired glucose tolerance and cardiovascular risk. This study tests the hypothesis that the lifestyle change which accompanies population migration, with attendant increases in cardiovascular risk, is reflected by changes in the IGF system.
MATERIALS AND METHODS: We compared a specific Gujarati community in Sandwell, UK (n=205), with people still resident in the same villages of origin near Navsari, India (n=246). We performed anthropometry and measured fasting plasma insulin, IGF-I, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3.
RESULTS: Daily calorie intake, BMI and WHR were significantly higher in UK Gujaratis than in Indian Gujaratis. IGFBP-1 was significantly lower in UK migrants (mean 29.5 [95% CI 25.9-33.0] vs 56.5 [50.6-62.5] microg/l; F=48.4, p<0.001). Conversely, fasting insulin, IGFBP-3 and IGF-I were all higher in UK Gujaratis (mean IGF-I 145.9 [138.1-153.6]ng/ml in UK Gujaratis and 100.9 [94.6-107.3] ng/ml in Navsari Gujaratis; F=76.6, p<0.001). These differences were still apparent when adjustment was made for BMI by location for IGF-I (F=57.4, p<0.001) and IGFBP-3 (F=5.7, p=0.02), but were no longer apparent for IGFBP-1 and insulin. At the population level, the decrease in IGFBP-1 for a given increase in insulin was significantly smaller in UK Gujaratis, suggesting greater hepatic insulin resistance in this group. CONCLUSIONS/
INTERPRETATION: Environmental factors have profound effects on circulating IGF system components and on the relationship between IGFBP-1, IGF-I and related metabolic variables. This may have long-term implications for the development of worsening glucose tolerance and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041536     DOI: 10.1007/s00125-005-1871-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure.

Authors:  J K Cruickshank; J Cooper; M Burnett; J MacDuff; U Drubra
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

2.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

Authors:  A H Heald; J K Cruickshank; L K Riste; J E Cade; S Anderson; A Greenhalgh; J Sampayo; W Taylor; W Fraser; A White; J M Gibson
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

3.  Clinical features, risk factors, and referral delay in British patients of Indian and European origin with angina matched for age and extent of coronary atheroma.

Authors:  N Shaukat; D P de Bono; J K Cruickshank
Journal:  BMJ       Date:  1993-09-18

4.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.

Authors:  Manjinder S Sandhu; Adrian H Heald; J Martin Gibson; J Kennedy Cruickshank; David B Dunger; Nicholas J Wareham
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

Review 5.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

6.  Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters.

Authors:  J J Ververis; L Ku; P Delafontaine
Journal:  Circ Res       Date:  1993-06       Impact factor: 17.367

7.  Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

Authors:  Adrian H Heald; K W Siddals; William Fraser; William Taylor; Kalpana Kaushal; Julie Morris; Robert J Young; Anne White; J Martin Gibson
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

8.  Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff.

Authors:  D J Maron; J M Fair; W L Haskell
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta.

Authors:  K A Fath; R W Alexander; P Delafontaine
Journal:  Circ Res       Date:  1993-02       Impact factor: 17.367

View more
  1 in total

1.  Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort.

Authors:  Therese Tillin; Alun D Hughes; Ian F Godsland; Peter Whincup; Nita G Forouhi; Paul Welsh; Naveed Sattar; Paul M McKeigue; Nish Chaturvedi
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.